Skip to main content

Advertisement

Log in

γ-Synuclein: Cell-Type-Specific Promoter Activity and Binding to Transcription Factors

  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

γ-Synuclein, also referred to as breast-cancer-specific gene 1, is the third member of the neuronal protein family synuclein. Synucleins attracted the attention of many investigators because of their role in human diseases. γ-Synuclein participates in the pathogenesis of several types of cancer and some neurodegenerative diseases. Its role in tumorigenesis is due to the upregulation of transcription and the effect on downstream targets, including signaling pathways and transcription factors. γ-Synuclein is also expressed in neurons and glial cells, but the regulation of its expression, as well as the mechanism of transition from normal functions to pathology in these cell types, is not studied. Here, we examined how γ-synuclein promoter is regulated in neuronal and glial cells. We also show that γ-synuclein is able to bind directly to several transcription factors. These results are discussed in connection with the implication of γ-synuclein in diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3

References

  • Benko, S., Love, J. D., Beládi, M., Schwabe, J. W. R., & Nagy, L. (2003). Molecular determinants of the balance between co-repressor and co-activator recruitment to the retinoic acid receptor. Journal of Biological Chemistry, 278, 43797–43806.

    Article  PubMed  CAS  Google Scholar 

  • Bruening, W., Giasson, B., Klein-Szanto, J., Lee, V., Trojanowski, J., & Godwin, A. (2000). Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary. Cancer, 88, 2154–2163.

    Article  PubMed  CAS  Google Scholar 

  • Buchman, V. L., Hunter, H. J., Pinõn, L. G., et al. (1998). Persyn, a member of the synuclein family, has a distinct pattern of expression in the developing nervous system. Journal Neuroscience, 18, 9335–9341.

    CAS  Google Scholar 

  • Galvin, J. E., Uryu, K., Lee, V. M.-Y., & Trojanowski, J. Q. (1999). Axon pathology in Parkinson’s disease and Lewy body dementia hippocampus contains a-, b-, and γ-synuclein. Proceedings of National Academy of Sciences of the United States of America, 96, 13450–13455.

    Article  CAS  Google Scholar 

  • Galvin, J. E., Giasson, B., Hurtig, H. I., Lee, V. M.-Y., & Trojanowski, J. Q. (2000). Neurodegeneration with brain iron accumulation, type 1 is characterized by a-, b-, and γ-synuclein neuropathology. American Journal of Pathology, 157, 361–368.

    PubMed  CAS  Google Scholar 

  • George, J. M. (2002). The synucleins. Genome Biology, 3, 1–6.

    Google Scholar 

  • Goodbourn, S., & Maniatis, T. (1988). Overlapping positive and negative regulatory domains of the human beta-interferon gene. Proceedings of National Academy of Sciences of the United States of America, 85, 1447–1451.

    Article  CAS  Google Scholar 

  • Ji, H., Liu, Y., Jia, T., et al. (1997). Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing. Cancer Research, 57, 759–764.

    PubMed  CAS  Google Scholar 

  • Jiang, Y. F., Liu, Y. E., Lu, A., et al. (2003). Stimulation of estrogen receptor signaling by gamma synuclein. Cancer Research, 63, 3899–3903.

    PubMed  CAS  Google Scholar 

  • Jiang, Y. F., Liu, Y. A., Goldberg, I. D., & Shi, Y. E. (2004). γ-Synuclein, a novel heat-shock protein-associated chaperone, stimulates ligand-dependent estrogen receptor alpha signaling and mammary tumorigenesis. Cancer Research, 64, 4539–4546.

    Article  PubMed  CAS  Google Scholar 

  • Larose, M., Cassard-Doulcier, A. M., Fleury, C., et al. (1996). Essential cis-acting elements in rat uncoupling protein gene are in an enhancer containing a complex retinoic acid response domain. Journal of Biological Chemistry, 271, 31533–31542.

    Article  PubMed  CAS  Google Scholar 

  • Leung, T., Bischof, J., Söll, I., et al. (2003). Bozozok directly represses bmp2b transcription and mediates the earliest dorsoventral asymmetry of bmp2b expression in zebrafish. Development, 130, 3639–3649.

    Article  PubMed  CAS  Google Scholar 

  • Liu, J., Spence, M. J., Zhang, Y. L., Jiang, Y., Liu, Y., & Shi, Y. (2000). Transcriptional suppression of synuclein gamma (SNCG) expression in human breast cancer cells by the growth inhibitory cytokine oncostatin M. Breast Cancer Research and Treatment, 62, 99–107.

    Article  PubMed  CAS  Google Scholar 

  • Li, J. Y., Henning Jensen, P., & Dahlström, A. (2002). Differential localization of alpha-, beta- and gamma-synucleins in the rat CNS. Neuroscience, 113, 463–478.

    Article  PubMed  CAS  Google Scholar 

  • Lu, A., Gupta, A., Li, C., et al. (2001). Molecular mechanisms for aberrant expression of the human breast cancer specific gene 1 in breast cancer cells: control of transcription by DNA methylation and intronic sequences. Oncogene, 20, 5173–5185.

    Article  PubMed  CAS  Google Scholar 

  • Lu, A., Zhang, F., Gupta, A., & Liu, J. (2002). Blockade of AP1 transactivation abrogates the abnormal expression of the breast cancer-specific gene 1 in breast cancer cells. Journal of Biological Chemistry, 277, 31364–31372.

    Article  PubMed  CAS  Google Scholar 

  • Surgucheva, I., McMahan, B., Ahmed, F., Tomarev, S., Wax, M. B., & Surguchov, A. (2002). Synucleins in glaucoma: Implication of gamma-synuclein in glaucomatous alterations in the optic nerve. Journal of Neuroscience Research, 68, 97–106.

    Article  PubMed  CAS  Google Scholar 

  • Surgucheva, I. G., Sivak, J. M., Fini, M. E., Palazzo, R. E., & Surguchov, A. P. (2003). Effect of gamma-synuclein overexpression on matrix metalloproteinases in retinoblastoma Y79 cells. Archives of Biochemistry and Biophysics, 410, 167.

    Article  PubMed  CAS  Google Scholar 

  • Surgucheva, I., McMahon, B., & Surguchov, A. (2006). Gamma-synuclein has a dynamic intracellular localization. Cell Motility and the Cytoskeleton, 63, 447–458.

    Article  PubMed  CAS  Google Scholar 

  • Surguchov, A., Palazzo, R. E., & Surgucheva, I. (2001). Gamma synuclein: Subcellular localization in neuronal and non-neuronal cells and effect on signal transduction. Cell Motility and the Cytoskeleton, 49, 218–228.

    Article  PubMed  CAS  Google Scholar 

  • Teelt-Hansen, J., Yano, S., Bandyopadhyay, S., Carroll, R., Brown, E. N., & Chattopadhyay, N. (2004). Expression of pituitary tumor transforming gene (PTTG) and its binding protein in human astrocytes and astrocytoma cells: function and regulation of PTTG in U87 astrocytoma cells. Endocrinology, 145, 4222–4231.

    Article  Google Scholar 

  • Varghese, S., Rydziel, S., & Canalis, E. (2005). Bone morphogenetic protein-2 suppresses collagenese-3 promoter activity in osteoblasts through a runt domain factor 2 binding site. Journal of Cellular Physiology, 202, 391–399.

    Article  PubMed  CAS  Google Scholar 

  • Wu, K., Weng, Z., Tao, Q., et al. (2003). Stage-specific expression of breast cancer-specific gene gamma-synuclein. Cancer Epidemiology, Biomarkers and Prevention.12, 920–925.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Neeraj Agarwal (University of North Texas Health Science Center, Fort Worth, TX, USA) for RGC-5 cells and Dr. H. Geller (Department of Pharmacology Robert Wood Johnson Medical School) for the culture of A7 astrocytes. This work is supported by NIH grant EY 02687, VA Merit Review grant, and The Glaucoma Foundation grant QB42308. The technical help of Ms. Kristin Cain is acknowledged.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrei Surguchov.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Surgucheva, I., Surguchov, A. γ-Synuclein: Cell-Type-Specific Promoter Activity and Binding to Transcription Factors. J Mol Neurosci 35, 267–271 (2008). https://doi.org/10.1007/s12031-008-9074-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12031-008-9074-6

Keywords

Navigation